AMPAR antagonist enhance the effect of temozolomide and radiation on glioblastoma cell

被引:0
|
作者
Yoshida, Y. [1 ,2 ]
Ishiuchi, S. [2 ,3 ]
Suzuki, Y. [1 ]
Nakano, T. [1 ,2 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch Med, 21st Century COE Program, Maebashi, Gunma, Japan
[3] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma, Japan
关键词
D O I
10.1016/j.ijrobp.2007.07.1926
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2744
引用
收藏
页码:S612 / S613
页数:2
相关论文
共 50 条
  • [1] Valproic Acid and Celecoxib Enhance the Effect of Temozolomide on Glioblastoma Cells
    Pak, Oleg
    Kosianova, Aleksandra
    Zaitsev, Sergei
    Sharma, Aruna
    Sharma, Hari
    Bryukhovetskiy, Igor
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024,
  • [2] The effect of flubendazole on temozolomide treatment in glioblastoma cell
    Dvorakova, K.
    Vitovcova, B.
    Skarka, A.
    Caltova, K.
    Rudolf, E.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1410 - S1411
  • [3] Temozolomide Effect on Mitophagy in Glioblastoma Chemoresistance Cell Lines
    Javed, R.
    Liu, X.
    Akhter, F.
    Zhou, J.
    Liu, X.
    He, L.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S305 - S306
  • [4] Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
    Rodrigues-Junior, Dorival Mendes
    Raminelli, Cristiano
    Hassanie, Haifa
    Goulart Trossini, Gustavo Henrique
    Perecim, Givago Prado
    Caja, Laia
    Moustakas, Aristidis
    Vettore, Andre Luiz
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
    Dorival Mendes Rodrigues-Junior
    Cristiano Raminelli
    Haifa Hassanie
    Gustavo Henrique Goulart Trossini
    Givago Prado Perecim
    Laia Caja
    Aristidis Moustakas
    André Luiz Vettore
    Scientific Reports, 12
  • [6] Radiation plus Temozolomide in Patients with Glioblastoma
    Rusthoven, Chad G.
    Koshy, Matthew
    Sher, David J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22): : 2195 - 2197
  • [7] Clinical Outcomes of Small Cell Glioblastoma or Glioblastoma With Oligodendroglioma Component Treated With Radiation Therapy and Temozolomide
    Huang, J.
    Badiyan, S. N.
    Cai, C.
    Robinson, C. G.
    Dahiya, S.
    Tran, D. D.
    Kim, A. H.
    Dunn, G. P.
    Campian, J. L.
    Chicoine, M. R.
    Simpson, J. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S293 - S294
  • [8] Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
    Pandey, Arvind
    Tripathi, Satyendra C.
    Mai, Junhua
    Hanash, Samir M.
    Shen, Haifa
    Mitra, Sankar
    Rostomily, Robert C.
    CANCERS, 2021, 13 (20)
  • [9] Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma
    Jimenez, Rafael
    Constantinescu, Andrada
    Yazir, Muhube
    Alfonso-Triguero, Paula
    Pequerul, Raquel
    Pares, Xavier
    Perez-Alea, Mileidys
    Candiota, Ana Paula
    Farres, Jaume
    Lorenzo, Julia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [10] Tumor Treating Fields (TTFields) Enhance the Efficacy of Temozolomide and Lomustine in Glioblastoma Cell Lines
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E70 - E70